TABLE 4.

Association Between ¹⁸F-FDG PET/CT Parameters and OS, RFS, and CFS (Univariate Analysis)

		HR
Parameter	Category	OS	RFS	CFS
Baseline ¹⁸F-FDG PET/CT	SUV_max (T)	1.06 (1–1.12), P = 0.038	1.05 (1.01–1.1), P = 0.018	1.06 (1.01–1.11), P = 0.019
	SUV_peak (T)	1.09 (1.01–1.17), P = 0.022	1.09 (1.02–1.15), P = 0.007	1.09 (1.02–1.16), P = 0.010
	SUV_mean (T)	1.02 (0.97–1.07), P = 0.385	1.02 (0.98–1.06), P = 0.333	1.02 (0.98–1.06), P = 0.342
	MTV 41% (T)	1.03 (1.01–1.05), P = 0.001	1.02 (1–1.03), P = 0.023	1.02 (1.01–1.04), P = 0.002
	TLG (T)	1.00 (1–1), P < 0.001	1.00 (1–1), P = 0.009	1.00 (1–1), P = 0.001
	MTV 41% (N)	1.06 (1.02–1.1), P = 0.002	1.06 (1.03–1.1), P < 0.001	1.06 (1.02–1.1), P = 0.001
	MTV 41% (T + N)	1.03 (1.01–1.04), P < 0.001	1.02 (1–1.03), P = 0.005	1.02 (1.01–1.04), P = 0.001
	TLG (N)	1.01 (1–1.01), P = 0.025	1.01 (1–1.01), P = 0.001	1.01 (1–1.01), P = 0.029
	TLG (T + N)	1.00 (1–1), P < 0.001	1.00 (1–1), P = 0.004	1.00 (1–1), P < 0.001
Posttreatment ¹⁸F-FDG PET/CT	SUV_max	1.30 (1.14–1.49), P < 0.001	1.21 (1.09–1.34), P < 0.001	1.32 (1.19–1.48), P < 0.001
Both	Change in SUV_max	1.00 (0.98–1.02), P = 0.889	1.00 (0.99–1.02), P = 0.888	1.00 (0.98–1.01), P = 0.487

Data in parentheses are 95% CIs.